| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 27 |
| 1 | SILDENAFIL CITRATE | 11 |
| 2 | MACITENTAN | 8 |
| 3 | AMBRISENTAN | 7 |
| 4 | SILDENAFIL | 7 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 6 |
| 6 | ACETAMINOPHEN | 5 |
| 7 | GABAPENTIN | 5 |
| 8 | LIDOCAINE | 5 |
| 9 | LIDOCAINE HYDROCHLORIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHOXSALEN | 1 | 0.0079 |
| 1 | RITUXIMAB AND HYALURONIDASE | 1 | 0.0022 |
| 2 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 3 | KETAMINE HYDROCHLORIDE | 3 | 0.0006 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 5 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 6 | DEFLAZACORT | 1 | 0.0004 |
| 7 | ENFORTUMAB VEDOTIN | 3 | 0.0004 |
| 8 | METHIMAZOLE | 3 | 0.0004 |
| 9 | SOTATERCEPT-CSRK | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 2 | Prostacycline Vasodilator [EPC] | 27 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Amide Local Anesthetic [EPC] | 8 | 0.0001 |
| 8 | Antiarrhythmic [EPC] | 8 | 0.0001 |
| 9 | Endothelin Receptor Antagonist [EPC] | 15 | 0.0001 |